Numinus acquires a Montreal-based provider of psychedelic-assisted psychotherapies.
Exploring the companies and themes that make up this emerging and exciting new sector
MindMed Announces $50 Million Bought Deal Public Offering
MindMed continues to raise capital. This time issuing 11,364,000 units at CAD$4.40 for gross proceeds of CAD$50,001,600.
MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy
MindMed announces a successful pre-Investigational New Drug meeting with the FDA regarding its Project Lucy (LSD) research for anxiety.
Psychedelic Stocks Pump Up The Volume
Psychedelic stocks are hitting new highs -- and doing so on record trading volumes. Feeding frenzies.
MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m)
MindMed's recent financing has closed after being upsized all the way to CAD$34.5 million.
Mind Cure (CSE: MCUR | OTC: MCURF) Moves into Psychedelic Assisted Therapy with British Columbia Location Offering Ketamine and Psilocybin Therapy
The company is set to open a therapeutic health and training center in Kelowna, British Columbia in May of 2021
Rotation Opportunity As Three Top Psychedelic Stocks Explode
Leading psychedelic stocks have gone ballistic in recent weeks. But where will investors find the NEXT multi-bagger opportunity?
Entheon Biomedical Announces DMT Drug Supply Agreement with Psygen Labs Inc. Completion of Initial DMT Research Drug Batch and Exercise of Warrants
Entheon has secured a supply of DMT for delivery to its drug research center (CHDR) in the Netherlands.
Champignon Brands Appoints Christopher Hobbs as Interim Chief Financial Officer
Champignon Brands names an interim CFO after Stephen Brohman resigns.
Mind Cure Announces its Research Program with Psychedelic Compounds
Mind Cure's initial R&D focus will be on psilocybin, ketamine and ibogaine. Researching both pain and mental health applications for psychedelics.
The Hottest Biotech In 2021
Warning: This is probably not for you.
Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms
Mydecine completes its first commercial harvest of 20 kilograms of psilocybin mushrooms.